130 related articles for article (PubMed ID: 12048130)
1. Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease.
Dugi KA; Schmidt N; Brandauer K; Ramacher D; Fiehn W; Kreuzer J
Atherosclerosis; 2002 Jul; 163(1):127-34. PubMed ID: 12048130
[TBL] [Abstract][Full Text] [Related]
2. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
[TBL] [Abstract][Full Text] [Related]
4. [Extent of coronary sclerosis in relation to lipoprotein lipase activity and plasma triglyceride levels].
Breier C; Mühlberger V; Herold M; Drexel H; Lisch HJ; Knapp E; Braunsteiner H
Schweiz Med Wochenschr; 1985 Sep; 115(37):1263-7. PubMed ID: 4059897
[TBL] [Abstract][Full Text] [Related]
5. Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.
Rip J; Nierman MC; Wareham NJ; Luben R; Bingham SA; Day NE; van Miert JN; Hutten BA; Kastelein JJ; Kuivenhoven JA; Khaw KT; Boekholdt SM
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):637-42. PubMed ID: 16373616
[TBL] [Abstract][Full Text] [Related]
6. The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.
Muraba Y; Koga T; Shimomura Y; Ito Y; Hirao Y; Kobayashi J; Kimura T; Nakajima K; Murakami M
Clin Chim Acta; 2018 Jan; 476():146-153. PubMed ID: 29174344
[TBL] [Abstract][Full Text] [Related]
7. The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease.
Agirbasli M; Sumerkan MC; Eren F; Agirbasli D
Heart Vessels; 2011 Jul; 26(4):457-63. PubMed ID: 21127884
[TBL] [Abstract][Full Text] [Related]
8. Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease.
Breier C; Mühlberger V; Drexel H; Herold M; Lisch HJ; Knapp E; Braunsteiner H
Lancet; 1985 Jun; 1(8440):1242-4. PubMed ID: 2860444
[TBL] [Abstract][Full Text] [Related]
9. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
Gaudet D; Vohl MC; Julien P; Tremblay G; Perron P; Gagné C; Bergeron J; Moorjani S; Després JP
Am J Cardiol; 1998 Aug; 82(3):299-305. PubMed ID: 9708657
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia.
Dugi KA; Feuerstein IM; Hill S; Shih J; Santamarina-Fojo S; Brewer HB; Hoeg JM
Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):354-64. PubMed ID: 9081692
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis.
Xie L; Li YM
Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28275220
[TBL] [Abstract][Full Text] [Related]
12. Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans.
Goldberg IJ; Vanni-Reyes T; Ramakrishnan S; Holleran S; Ginsberg HN
J Cardiovasc Risk; 2000 Feb; 7(1):41-7. PubMed ID: 10785873
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins.
Henderson HE; Kastelein JJ; Zwinderman AH; Gagné E; Jukema JW; Reymer PW; Groenemeyer BE; Lie KI; Bruschke AV; Hayden MR; Jansen H
J Lipid Res; 1999 Apr; 40(4):735-43. PubMed ID: 10191298
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.
Sing K; Ballantyne CM; Ferlic L; Brugada R; Cushman I; Dunn JK; Herd JA; Pownall HJ; Gotto AM; Marian AJ
Atherosclerosis; 1999 Jun; 144(2):435-42. PubMed ID: 10407505
[TBL] [Abstract][Full Text] [Related]
15. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
16. The level of pre-heparin serum lipoprotein lipase mass at different stages of pregnancy.
Kinoshita T; Shirai K; Itoh M
Clin Chim Acta; 2003 Nov; 337(1-2):153-6. PubMed ID: 14568192
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis.
Auer J; Rammer M; Berent R; Weber T; Lassnig E; Eber B
Acta Cardiol; 2002 Dec; 57(6):409-14. PubMed ID: 12542118
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein lipase and atherosclerosis.
Tsutsumi K
Curr Vasc Pharmacol; 2003 Mar; 1(1):11-7. PubMed ID: 15320848
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein lipase and premature coronary artery disease.
Chen Z; Ma G; Zhang X; Wang J
Acta Cardiol; 2009 Jun; 64(3):379-83. PubMed ID: 19593950
[TBL] [Abstract][Full Text] [Related]
20. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
